L vs OGEN · P/E 14, rev $18.45B vs rev $37.7K
Loews Corp (L) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
L currently screens at market cap $22.36B and trailing P/E 13.8. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the L and OGEN stock pages for the full models.
Not investment advice.